Pfizer Ltd.

Expensive Performer

Check Buy or Sell

4620.15 9.55 (0.21%)

33.49% Gain from 52W Low

32 Volume

NSEMar 05, 2021 09:07 AM

Watchlist

Portfolio

Alert

Share

11S
3W
1O
3T
21,137.2

Market Cap

High in industry

5,468.7

AVG Broker Target

18.37% upside

42.3

TTM PE Ratio

High in industry

-14

TTM PEG Ratio

Negative PEG TTM Price to Earnings Growth

6.2

Price to Book Ratio

Above industry Median



Pfizer Ltd.    
04 Mar 2021, 05:23PM
4620.15
0.21%
When will children be able to get COVID-19 vaccines?
When will children be able to get COVID-19 vaccines?
Moneycontrol
Pfizer and Moderna both have completed enrollment for studies of children ages 12 and older, and expect to release the data over the summer. If regulators clear the results, younger teens likewise could start getting vaccinated once supply allows. The Moderna vaccine is currently cleared for people 18 and older.
Pfizer Ltd. is trading above it's 30 day SMA of 4571.0
Pfizer first dose effective after 11 days; no need of second booster: Study
Business Line | 04 Mar 2021, 10:16AM
Pfizer Ltd.    
03 Mar 2021, 10:59PM
4620.15
0.21%
Business Today
So far, the Pfizer-BioNTtech and Moderna vaccines, made through a novel platform technology never used in humans before, are proven to have maximum efficacy
default
Pfizer Ltd. is trading below it's 50 day SMA of 4799.2
Pfizer Ltd.    
03 Mar 2021, 11:27AM
4620.15
0.21%
Business Today
White House press secretary Jen Psaki also announced Tuesday that the federal government was increasing supply of the Moderna and Pfizer vaccines to states next week to 15.2 million doses per week, up from 14.5 million previously
Pfizer Ltd. is trading below it's 50 day SMA of 4799.2
US FDA approves Johnson & Johnson's single-dose COVID-19 vaccine
Economic Times | 02 Mar 2021 2 more
Pfizer Ltd.    
02 Mar 2021
4620.15
0.21%
Business Standard
Fauci said on Sunday he was encouraging Americans to accept any of the three available Covid-19 vaccines
Pfizer Ltd. is trading below it's 50 day SMA of 4799.2
Pfizer, Oxford-AstraZeneca jabs reduce severe COVID-19 in people above 70 years: PHE study
Business Today | 02 Mar 2021 3 more
Pfizer Ltd.    
01 Mar 2021
4620.15
0.21%
Business Standard
At an industry forum last May, Pfizer's CEO Albert Bourla described the idea of sharing IP rights widely as nonsense and even dangerous
default
Pfizer Ltd. is trading above it's 30 day SMA of 4571.0
Pfizer Ltd.    
01 Mar 2021
4620.15
0.21%
Business Line
A new study has revealed that the Pfizer-BioNtech COVID-19 vaccine might be less effective on obese people, media reports said.The study carried out b
Pfizer Ltd. is trading below it's 50 day SMA of 4799.2
Pfizer Ltd.    
26 Feb 2021
4620.15
0.21%
Business Standard
The study and its results have yet to be independently peer-reviewed by other scientists
Pfizer Ltd. is trading above it's 30 day SMA of 4571.0
Astra, Sputnik vaccines face hurdles if Covid shots become annual affair
Business Standard | 26 Feb 2021 8 more
Pfizer Ltd.    
23 Feb 2021
4620.15
0.21%
Business Today
Data analysed by Public Health England (PHE) showed the Pfizer provided high levels of protection against infection and symptomatic disease from a single dose
Pfizer Ltd. is trading below it's 50 day SMA of 4799.2
COVID-19 vaccine: Pfizer to ship 13 million doses per week to US by mid-March
Business Today | 23 Feb 2021
Pfizer Ltd.    
22 Feb 2021
4620.15
0.21%
Business Line
Domestic regulators have only approved one vaccine so far Pfizer's
Pfizer Ltd. is trading below it's 50 day SMA of 4799.2
Pfizer Ltd.    
22 Feb 2021
4620.15
0.21%
Business Standard
The British government announced Sunday that it aims to give every adult in the country a first dose of coronavirus vaccine by July 31, a month earlier than its previous target. The new target also aims for everyone over 50 or with an underlying health condition to get a vaccine shot by April 15, rather than the previous target of May 1. The makers of the two vaccines that Britain is using, Pfizer and AstraZeneca, have both experienced supply problems in Europe. But UK Health Secretary Matt Hancock, who announced the new targets, said we now think that we have the supplies to speed up the vaccination campaign. The early success of Britain's vaccination campaign is welcome good news for a country that has had more than 120,000 coronavirus deaths, the highest toll in Europe. More than 17.2 million people, almost a third of the country's adults, have been given the first of two doses of vaccine since inoculations began on December 8. Britain is delaying giving second vaccine doses un
default
Pfizer Ltd. is trading above it's 30 day SMA of 4571.0
COVID-19 illness risk fell 95.8% after both Pfizer vaccine doses, says Israel
Business Today | 21 Feb 2021
Is Pfizer Ltd. worth buying?
Total Votes: 142
BUY
SELL
HOLD
78.87%
13.38%
7.75%
  • Nirmal Bang Institutional decreased Accumulate price target of Pfizer Ltd. to 4716.0 on 08 Feb, 2021.
  • Stock Price (4637.1) crossed below 200 Day SMA (4698.24) on 29 January, 2021
  • Stock Price (4944.65) crossed below 100 Day SMA (5048.76) on 18 January, 2021
  • Stock Price (5279.4) crossed above 30 Day SMA (5199.52) on 01 January, 2021
  • Stock Price (5279.4) crossed above 50 Day SMA (5134.84) on 01 January, 2021
More triggered alerts
Ex-Date Dividend Amount Dividend Type Record Date
Aug. 27, 202010.00FINAL-
May 6, 2020320.00SPECIALMay 8, 2020
Aug. 1, 201922.50FINAL-
Aug. 29, 201820.00FINAL-
Aug. 22, 20175.00SPECIAL-
All dividends by PFIZER
Ex-Date Dividend Bonus Ratio Record Date
June 12, 20001:1June 28, 2000
All bonuses by PFIZER